Atlas Trials

The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China

Clinical trial NCT02143739 · COMPLETED

Trial details

NCT number
NCT02143739
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Asthma
Start date
2014-06-07
Primary completion
2016-09-15
Enrollment
4817

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.